193 related articles for article (PubMed ID: 33020176)
21. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
22. The association of Crk-like adapter protein with poor prognosis in glioma patients.
Yao C; Lv S; Han M; Zhang J; Zhang Y; Zhang L; Yi R; Zhuang D; Wu J
Tumour Biol; 2014 Jun; 35(6):5695-700. PubMed ID: 24563280
[TBL] [Abstract][Full Text] [Related]
23. Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.
Thorarinsdottir HK; Santi M; McCarter R; Rushing EJ; Cornelison R; Jales A; MacDonald TJ
Clin Cancer Res; 2008 Jun; 14(11):3386-94. PubMed ID: 18519768
[TBL] [Abstract][Full Text] [Related]
24. Ki-67: a prognostic factor for low-grade glioma?
Fisher BJ; Naumova E; Leighton CC; Naumov GN; Kerklviet N; Fortin D; Macdonald DR; Cairncross JG; Bauman GS; Stitt L
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):996-1001. PubMed ID: 11958894
[TBL] [Abstract][Full Text] [Related]
25. Additive effect on survival of Raf kinase inhibitor protein and signal transducer and activator of transcription 3 in high-grade glioma.
Maresch J; Birner P; Zakharinov M; Toumangelova-Uzeir K; Natchev S; Guentchev M
Cancer; 2011 Jun; 117(11):2499-504. PubMed ID: 24048798
[TBL] [Abstract][Full Text] [Related]
26. Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.
Yang P; Wang Y; Peng X; You G; Zhang W; Yan W; Bao Z; Wang Y; Qiu X; Jiang T
J Neurooncol; 2013 Jun; 113(2):259-66. PubMed ID: 23483435
[TBL] [Abstract][Full Text] [Related]
27. High Content Imaging Assays for IL-6-Induced STAT3 Pathway Activation in Head and Neck Cancer Cell Lines.
Johnston PA; Sen M; Hua Y; Camarco DP; Shun TY; Lazo JS; Grandis JR
Methods Mol Biol; 2018; 1683():229-244. PubMed ID: 29082496
[TBL] [Abstract][Full Text] [Related]
28. The role of phosphorylated signal transducer and activator of transcription 3 (pSTAT3) in peripheral nerve sheath tumours.
Panse G; Leung CH; Ingram DR; Wani K; Torres KE; Lin H; Lazar AJ; Wang WL
Histopathology; 2017 May; 70(6):946-953. PubMed ID: 27992966
[TBL] [Abstract][Full Text] [Related]
29. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma.
Doucette TA; Kong LY; Yang Y; Ferguson SD; Yang J; Wei J; Qiao W; Fuller GN; Bhat KP; Aldape K; Priebe W; Bögler O; Heimberger AB; Rao G
Neuro Oncol; 2012 Sep; 14(9):1136-45. PubMed ID: 22753228
[TBL] [Abstract][Full Text] [Related]
30. Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis.
Pan Y; Yuan F; Li Y; Wang G; Lin Z; Chen L
Oncol Rep; 2019 Jan; 41(1):246-256. PubMed ID: 30542695
[TBL] [Abstract][Full Text] [Related]
31. Expression of FAS-L Differs from Primary to Relapsed Low-grade Gliomas and Predicts Progression-free Survival.
Werner JM; Kuhl S; Stavrinou P; Röhn G; Krischek B; Blau T; Goldbrunner R; Timmer M
Anticancer Res; 2017 Dec; 37(12):6639-6648. PubMed ID: 29187439
[TBL] [Abstract][Full Text] [Related]
32. Expression of cyclinD1 and Ki-67 proteins in gliomas and its clinical significance.
Qu DW; Xu HS; Han XJ; Wang YL; Ouyang CJ
Eur Rev Med Pharmacol Sci; 2014; 18(4):516-9. PubMed ID: 24610618
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas.
Wang L; Qin H; Li L; Zhang Y; Tu Y; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
Med Oncol; 2012 Dec; 29(5):3491-7. PubMed ID: 22926920
[TBL] [Abstract][Full Text] [Related]
34. Association of pSTAT3-VEGF signaling pathway with peritumoral edema in newly diagnosed glioblastoma: an immunohistochemical study.
Wang XF; Lin GS; Lin ZX; Chen YP; Chen Y; Zhang JD; Tan WL
Int J Clin Exp Pathol; 2014; 7(9):6133-40. PubMed ID: 25337261
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the expression and prognostic value of MT1-MMP, β1-integrin and YAP1 in glioma.
Zhai Y; Sang W; Su L; Shen Y; Hu Y; Zhang W
Open Med (Wars); 2022; 17(1):492-507. PubMed ID: 35350840
[TBL] [Abstract][Full Text] [Related]
36. pSTAT3 expression associated with survival and mammographic density of breast cancer patients.
Radenkovic S; Konjevic G; Gavrilovic D; Stojanovic-Rundic S; Plesinac-Karapandzic V; Stevanovic P; Jurisic V
Pathol Res Pract; 2019 Feb; 215(2):366-372. PubMed ID: 30598340
[TBL] [Abstract][Full Text] [Related]
37. Perfusion MRI grading diffuse gliomas: Impact of permeability parameters on molecular biomarkers and survival.
Hilario A; Hernandez-Lain A; Sepulveda JM; Lagares A; Perez-Nuñez A; Ramos A
Neurocirugia (Astur : Engl Ed); 2019; 30(1):11-18. PubMed ID: 30143443
[TBL] [Abstract][Full Text] [Related]
38. WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial.
Varlet P; Le Teuff G; Le Deley MC; Giangaspero F; Haberler C; Jacques TS; Figarella-Branger D; Pietsch T; Andreiuolo F; Deroulers C; Jaspan T; Jones C; Grill J
Neuro Oncol; 2020 Jan; 22(1):116-127. PubMed ID: 31419298
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
Liu Y; Deng J; Luo X; Pan Y; Zhang L; Zhang R; Liang H
Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients.
Ulyte A; Katsaros VK; Liouta E; Stranjalis G; Boskos C; Papanikolaou N; Usinskiene J; Bisdas S
Neuroradiology; 2016 Dec; 58(12):1197-1208. PubMed ID: 27796446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]